Tenaya Therapeutics Inc. (TNYA) Statistics & Valuation Metrics - Stocknear

Tenaya Therapeutics Inc.

NASDAQ: TNYA · Real-Time Price · USD
1.35
0.11 (8.87%)
At close: Sep 05, 2025, 3:59 PM
1.34
-0.74%
After-hours: Sep 05, 2025, 07:44 PM EDT

Tenaya Therapeutics Statistics

Share Statistics

Tenaya Therapeutics has 162.98M shares outstanding. The number of shares has increased by 106.2% in one year.

162.98M
106.2%
0.05%
43.84%
137.66M
30,473
0.98%

Short Selling Information

The latest short interest is 11.92M, so 7.31% of the outstanding shares have been sold short.

11.92M
7.31%
20.09%
4.28

Valuation Ratios

The PE ratio is -1.09 and the forward PE ratio is -2.21. Tenaya Therapeutics's PEG ratio is 0.05.

-1.09
-2.21
0
66
1.31
-1.33
0.05
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Tenaya Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 4.22, with a Debt / Equity ratio of 0.15.

4.22
4.22
0.15
-0.13
-0.15
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.15M
97
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -41.56% in the last 52 weeks. The beta is 3.08, so Tenaya Therapeutics's price volatility has been higher than the market average.

3.08
-41.56%
0.86
1.05
72.68
3,101,474

Income Statement

n/a
n/a
-115.95M
-111.13M
-102.66M
-111.13M
-1.31
Full Income Statement

Balance Sheet

The company has 4.32M in cash and 13.61M in debt, giving a net cash position of -9.29M.

4.32M
13.61M
-9.29M
-514.41M
122.15M
63.22M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -90.5M and capital expenditures -1.02M, giving a free cash flow of -91.53M.

-90.5M
-1.02M
-91.53M
-1.08
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

TNYA does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for TNYA is $5.5, which is 307.4% higher than the current price. The consensus rating is "Buy".

$5.5
307.4%
Buy
4
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-3.53
2